G3P is a development-stage company located in Burlington, Massachusetts. We pursue nutrional and other natural galectin-3 inhibitors.
The company was founded by thought leaders in the field of galectin-3 biology, cardiovascular pharmaceutical development, and carbohydrate drug synthesis and manufacturing. The galectin-3 research by our founders has been cited in the scientific literature over 2,000 times – a testimony to the importance of their studies in understanding the role of galectin-3 and the opportunity for treatment. We pursue natural products including enriched supplements that contain plant-derived inhibitors to supplement dietary intake of natural galectin-3 inhibitors.